Threshold Pharma (THLD) Receives Two U.S. Patents Covering Tarloxotinib Bromide
Tweet Send to a Friend
Threshold Pharma (NASDAQ: THLD) announced that the U.S. Patent and Trademark Office (USPTO) has issued the first two U.S. patents ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE